Kymera Therapeutics
KYMR
KYMR
255 hedge funds and large institutions have $8.01B invested in Kymera Therapeutics in 2026 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 94 increasing their positions, 73 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
8% more funds holding in top 10
Funds holding in top 10: 13 → 14 (+1)
8% more call options, than puts
Call options by funds: $10.8M | Put options by funds: $9.95M
1% more funds holding
Funds holding: 253 → 255 (+2)
Holders
255
Holding in Top 10
14
Calls
$10.8M
Puts
$9.95M
Top Buyers
| 1 | +$383M | |
| 2 | +$219M | |
| 3 | +$22.7M | |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$21.9M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$18.1M |
Top Sellers
| 1 | -$41.4M | |
| 2 | -$18M | |
| 3 | -$13.5M | |
| 4 |
Squarepoint
New York
|
-$11.6M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
-$10.1M |
